Leukemia, Myelogenous, Chronic, BCR-ABL Positive, drug therapy

All categories
DBCAT005119Pharmacologic class

A DrugBank category of 1 drug.

Drugs

What you can answer from here — as of February 02, 2020

1DrugEach linked to its full drug card
Listed above
2Drug targetsEvery drug–target pair in the class, with bond type
Sign in

Which targets do Leukemia, Myelogenous, Chronic, BCR-ABL Positive, drug therapy share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In